Table 2 Lipid-lowering regimen used in each group.

From: Escalation of liPid-lOwering therapy in patientS wiTh vascular disease receiving HIGH-intensity statins: the retrospective POST-HIGH study

 

Escalation (n = 164)

Control (n = 328)

Atorvastatin 40 mg

–

68 (20.7)

Rosuvastatin 20 mg

–

249 (75.9)

Simvastatin 10 mg/ezetimibe 10 mg

–

11 (3.4)

Atorvastatin 80 mg or regimen with similar efficacya

8 (4.9)

–

Atorvastatin 20 mg/ezetimibe 10 mg or regimen with similar efficacyb

64 (39.0)

–

Atorvastatin 40 mg/ezetimibe 10 mg or regimen with similar efficacyc

92 (55.1)

–

  1. Each value is presented as number (%);
  2. a: atorvastatin 10 mg/ezetimibe 10 mg, rosuvastatin 5 mg/ezetimibe 10 mg, simvastatin 20 mg/ezetimibe 10 mg, pitavastatin 2 mg/ezetimibe 10 mg;
  3. b: rosuvastatin 10 mg/ezetimibe 10 mg, simvastatin 40 mg/ezetimibe 10 mg, pitavastatin 4 mg/ezetimibe 10 mg.
  4. c: rosuvastatin 20 mg/ezetimibe 10 mg.
Back to article page